相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings
Jose M. Trigo et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal
D. J. Allsop et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Cannabinoid Abuse and Addiction: Clinical and Preclinical Findings
L. V. Panlilio et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Cannabinoids and Epilepsy
Evan C. Rosenberg et al.
NEUROTHERAPEUTICS (2015)
Cannabinoids in the Treatment of Epilepsy
Daniel Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Fabio Arturo Iannotti et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Cannabidiol enhances microglial phagocytosis via transient receptor potential ( TRP) channel activation
Samia Hassan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis
Nathalie A. Desrosiers et al.
CLINICAL CHEMISTRY (2014)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences
Alexander Wong et al.
PSYCHOPHARMACOLOGY (2014)
Practical and statistical issues in missing data for longitudinal patient-reported outcomes
Melanie L. Bell et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2014)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Pharmacotherapies for cannabis dependence
Kushani Marshall et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine
Mateus M. Bergamaschi et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws
Mateus M. Bergamaschi et al.
CLINICAL CHEMISTRY (2013)
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Dayong Lee et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Wendy Swift et al.
PLOS ONE (2013)
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study
Louisa Degenhardt et al.
PLOS ONE (2013)
Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry
Karl B. Scheidweiler et al.
CLINICA CHIMICA ACTA (2012)
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
Antonio Waldo Zuardi et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
A survey of the potency of Japanese illicit cannabis in fiscal year 2010
Yukari Tsumura et al.
FORENSIC SCIENCE INTERNATIONAL (2012)
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania
Zana Bruci et al.
FORENSIC SCIENCE INTERNATIONAL (2012)
Quantifying the Clinical Significance of Cannabis Withdrawal
David J. Allsop et al.
PLOS ONE (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress
David J. Allsop et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Heterogeneity in the composition of marijuana seized in California
James Richard Burgdorf et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
A. Novotna et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers
Kenneth H. Levin et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Cannabinoid activation of peroxisome proliferator-activated receptors: Potential for modulation of inflammatory disease
S. E. O'Sullivan et al.
IMMUNOBIOLOGY (2010)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
Anna Mazur et al.
DRUG METABOLISM AND DISPOSITION (2009)
Comparison of cannabis and tobacco withdrawal: Severity and contribution to relapse
Alan J. Budney et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2008)
Cannabinoids and multiple sclerosis
Roger G. Pertwee
MOLECULAR NEUROBIOLOGY (2007)
Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts
Sandra B. Grauwiler et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes
Kazuhito Watanabe et al.
LIFE SCIENCES (2007)
Validation of new methods
Frank T. Peters et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Alan J. Budney et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
The cannabis withdrawal syndrome
AJ Budney et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Bupropion SR worsens mood during marijuana withdrawal in humans
M Haney et al.
PSYCHOPHARMACOLOGY (2001)